NASDAQ:INCR InterCure (INCR) Stock Price, News & Analysis $5.42 +0.05 (+0.93%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$5.33 -0.09 (-1.68%) As of 10/2/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOptions ChainOwnershipSEC Filings About InterCure Stock (NASDAQ:INCR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InterCure alerts:Sign Up Key Stats Today's Range$5.38▼$5.4250-Day Range$4.26▼$5.9552-Week Range$3.40▼$8.45Volume2,758 shsAverage Volume4,633 shsMarket Capitalization$59.29 millionP/E Ratio36.13Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview InterCure Ltd. is an Israeli medical cannabis company that operates through its Canndoc subsidiary. The company is involved in the cultivation, production, distribution and sale of medical cannabis products, serving patients through pharmacies, clinics and other authorized channels. Its product portfolio includes cannabis flower, oils and other medical cannabis formulations. InterCure has developed a vertically integrated business model that spans cultivation and manufacturing as well as wholesale and retail distribution, with operations primarily focused on Israel. InterCure has also pursued international expansion through partnerships, licensing arrangements and commercial activities in selected overseas markets, subject to local cannabis regulations. The company’s shares trade on the Nasdaq under the symbol INCR and on the Tel Aviv Stock Exchange.AI Generated. May Contain Errors. Read More InterCure Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreINCR MarketRank™: InterCure scored higher than 19% of companies evaluated by MarketBeat, and ranked 800th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingInterCure has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageInterCure has only been the subject of 1 research reports in the past 90 days.Read more about InterCure's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of InterCure is 36.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.Price to Earnings Ratio vs. SectorThe P/E ratio of InterCure is 36.13, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.67.Price to Book Value per Share RatioInterCure has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.05% of the float of InterCure has been sold short.Short Interest Ratio / Days to CoverInterCure has a short interest ratio ("days to cover") of 0.62, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InterCure has recently decreased by 32.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInterCure does not currently pay a dividend.Dividend GrowthInterCure does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for InterCure this week, compared to 1 article on an average week. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InterCure insiders have not sold or bought any company stock.Percentage Held by Insiders0.24% of the stock of InterCure is held by insiders.Percentage Held by Institutions8.34% of the stock of InterCure is held by institutions.Read more about InterCure's insider trading history. Receive INCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INCR Stock News HeadlinesTilray Brands (NASDAQ:TLRY) and InterCure (NASDAQ:INCR) Head-To-Head SurveyOctober 2 at 4:59 AM | americanbankingnews.comInterCure Regains Nasdaq Compliance After Delisting WarningSeptember 8, 2026 | tipranks.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 4 at 1:00 AM | Porter & Company (Ad)InterCure Regains Compliance with Nasdaq Minimum Bid Price RequirementSeptember 8, 2026 | globenewswire.comInterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?August 27, 2026 | insidermonkey.comInterCure Raises $5 Million in August Private Placement to Rebuild Nir Oz FacilityAugust 26, 2026 | tipranks.comInterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect DamagesAugust 24, 2026 | globenewswire.comIntercure Ltd (INCR) Stock Price, Quote, News & HistoryAugust 20, 2026 | benzinga.comSee More Headlines INCR Stock Analysis - Frequently Asked Questions How have INCR shares performed this year? InterCure's stock was trading at $4.55 at the start of the year. Since then, INCR stock has increased by 19.1% and is now trading at $5.42. When did InterCure's stock split? Shares of InterCure reverse split before market open on Monday, August 24th 2026.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, August 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. How do I buy shares of InterCure? Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InterCure own? Based on aggregate information from My MarketBeat watchlists, some other companies that InterCure investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Tesla (TSLA), Innovative Industrial Properties (IIPR) and AbbVie (ABBV). Company Calendar Today10/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 INCR's financial health is in the Green zone, according to TradeSmith. INCR has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:INCR CIK1857030 Webwww.intercure.co Phone972774605012FaxN/AEmployees285Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio36.13 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$78.47 million Price / Sales0.76 Cash FlowN/A Price / Cash FlowN/A Book Value$10.53 per share Price / Book0.51Miscellaneous Outstanding Shares10,940,000Free Float10,910,000Market Cap$59.29 million OptionableOptionable Beta1.43 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:INCR) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredElon will prove them wrong againElon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no ...Paradigm Press | SponsoredJP Morgan: SpaceX could unlock "the next phase of the space economy"In 2024, Dylan Jovine flagged an obscure space stock trading under $4 a share. It later climbed as high as $15...Behind the Markets | SponsoredFree Stock: Economist calls it “the world’s most important machine.”Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...Brownstone Research | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InterCure Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InterCure With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
